Back
Colgate-Palmolive Vs. Tandem Diabetes Care Industry Stock Comparison
Buy
66
CL
Colgate-Palmolive
Last Price:
94.12
Seasonality Move:
0.98%
Buy
55
TNDM
Tandem Diabetes Care
Last Price:
47.31
Seasonality Move:
11.25%
Buy
66
Colgate-Palmolive (CL)
is a Buy
Is Colgate-Palmolive a Buy, Sell or Hold?
- The current Colgate-Palmolive [CL] share price is $94.53. The Score for CL is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- CL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Tandem Diabetes Care (TNDM)
is a Buy
Is Tandem Diabetes Care a Buy, Sell or Hold?
- The current Tandem Diabetes Care [TNDM] share price is $46.93. The Score for TNDM is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- TNDM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CL Stock Price Chart
What is Colgate-Palmolive's stock price today?
-
The Colgate-Palmolive share price today is $94.53
The current trend is moderately bullish and CL is experiencing slight buying pressure.
TNDM Stock Price Chart
What is Tandem Diabetes Care's stock price today?
-
The Tandem Diabetes Care share price today is $46.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TNDM is experiencing slight selling pressure.
CL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.75 | Buy |
| Relative Strength Index (14 RSI): | 72.57 | Buy |
| Chaikin Money Flow: | 675725 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (87.76 - 94.08) | Buy |
| Bollinger Bands (100): | (81.98 - 90.54) | Buy |
TNDM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.49 | Buy |
| Relative Strength Index (14 RSI): | 72.39 | Buy |
| Chaikin Money Flow: | -78818 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.74 - 43.7) | Buy |
| Bollinger Bands (100): | (24.25 - 36.69) | Buy |
CL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 94.35 | Buy |
| 20-day SMA: | 92.07 | Buy |
| 50-day SMA: | 89.65 | Buy |
| 200-day SMA: | 80.38 | Buy |
| 8-day EMA: | 94.1 | Buy |
| 20-day EMA: | 92.43 | Buy |
| 50-day EMA: | 89.79 | Buy |
| 200-day EMA: | 83 | Buy |
TNDM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.61 | Buy |
| 20-day SMA: | 39.73 | Buy |
| 50-day SMA: | 35.14 | Buy |
| 200-day SMA: | 26.48 | Buy |
| 8-day EMA: | 44.5 | Buy |
| 20-day EMA: | 40.95 | Buy |
| 50-day EMA: | 36.09 | Buy |
| 200-day EMA: | 30.79 | Buy |
Colgate-Palmolive Earnings Growth & CL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $0.31 per share.
Tandem Diabetes Care Earnings Growth & TNDM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.15 per share, and an increase next year of $0.54 per share.
Colgate-Palmolive Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tandem Diabetes Care Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||